Important Safety Information: The most common adverse events in decreasing order of reported frequency are: decreased appetite,
depression/lethargy, shaking/shivering/tremor, vomiting, restlessness and anxiety, seizures, aggression, diarrhea, mydriasis, vocalization, weight
loss, panting, confusion, incoordination, and hypersalivation. Reconcile® chewable tablets are contraindicated for dogs with a history of seizures
or when used with MAOIs.
Reconcile chewable tablets are indicated for the treatment of canine separation anxiety in conjunction with a behavior modification plan. Federal
law restricts this drug to use by or on the order of a licensed veterinarian. Visit Reconcile.com to view full prescribing information.
Reward good behavior with
this limited-time offer
Flavored, chewable Reconcile® (fluoxetine hydrochloride) tablets,
in conjunction with the BOND
™
training program, are clinically
proven to help dogs that experience separation anxiety.
Buy five (5) bottles of Reconcile
®
90-count bottles (mix & match) or
fifteen
(15) bottles of Reconcile
®
30-count bottles (mix & match)
and receive one
(1) PetSafe Train
N Praise Treat Dispenser for free.
PRN® and Reconcile® are registered
trademarks of Pegasus Laboratories, Inc.
NOW AVAILABLE IN 90-COUNT BOTTLE SIZES!
TALK TO YOUR DISTRIBUTOR REPRESENTATIVE
TODAY ABOUT THIS LIMITED-TIME OFFER!
Offer runs from July 1, 2023 through August 31, 2023
Available only while supplies last. Allow a minimum of four
weeks for fulfillment. Visit PRNPromoClaim.com for
more information and submission instructions.
Teach your pet remotely with
treats! Handheld remote activates
the treat dispenser to reward your
pet for good behavior.
$75 VALUE
Endorsed by veterinary behaviorists
as a helpful training tool
